Suboxone (Buprenorphine/Naloxone) Film Products Liability Litigation
Scientific studies indicate that the acidity of Suboxone (buprenorphine/naloxone) formulations, especially the film, contributes to dental erosion and decay. FDA warnings issued in January 2022 confirm the risk of serious dental problems, including cavities and tooth loss, associated with the use of buprenorphine medicines dissolved in the mouth. Expert testimony and court filings support the causation theory that the drug's acidic properties directly damage dental enamel, leading to the injuries claimed in the litigation.
1,832
Pending actions
1,908
Total actions filed
Active
Status
02/02/2024
Established
Filing deadline
Order No. 12 issued on November 4, 2024, and subsequent case management orders set various procedural deadlines, including discovery and motion filings. The statute of limitations is a concern for those who began using Suboxone before January 2022, with some sources indicating a 2-4 year window depending on jurisdiction.
Who qualifies
Plaintiffs must have used Suboxone, particularly the film formulation, prior to certain dates (e.g., before June 2022), and experienced severe dental injuries such as decay, erosion, or tooth loss. While specific dosage or duration requirements are not explicitly detailed in public court orders, documented use and resulting injuries are essential. The litigation emphasizes injuries caused by the drug's acidity and formulation properties, with some concern for those who started use before January 2022 due to statute of limitations considerations.
Products involved
- Suboxone (buprenorphine/naloxone) film
- Belbuca
- Bunavail
- Cassipa
- Subutex
- Zubsolv
Alleged injuries
- severe dental injuries
- tooth decay
- dental erosion
- tooth loss
Bellwether trials
The bellwether trial schedule has been outlined with procedural updates in late 2025, but no recent verdicts or trial outcomes have been publicly reported as of March 2026.
Settlement landscape
Estimated settlement amounts per person range from $50,000 to $150,000, depending on injury severity. The MDL involves approximately 1,849 pending lawsuits with an estimated 11,000 plaintiffs. No court-approved settlements have been publicly announced as of March 2026.
Lead counsel
- Ashlie Case Sletvold
This page is generated from the official JPML pending-MDL report and public court records, refreshed monthly. It is provided for attorney reference and is not legal advice.
